Patent · US Active

Five- and six-membered compound, and preparation method therefor and pharmaceutical composition and use thereof

US12195479B2 · kind B2 · utility

0Cited by

1References

12Claims

0Family size

Assignee

Hangzhou Polymed Biopharmaceuticals, Inc. · CN

Inventors

Jason Shaoyun Xiang · Winchester, US
Lei Wu · San Diego, US
Rui Xu · Boulder, US
Qiang Zhang · Dalian, CN
Gang Yang · Nanhu, CN
Michael Xiang · Zhejiang, CN
Mixue Tong · Zhejiang, CN
Camille Xiang · Zhejiang, CN
Yuxin Liu · Zhejiang, CN
Suyue Wang · Hangzhou City, CN
Rui Yang · Jiaocheng District, CN

Key dates

Filing date	Dec 19, 2023
Grant date	Jan 14, 2025
Priority date	—
Expiry date	Dec 19, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A five-membered-fused six-membered compound, and a preparation method therefor and a pharmaceutical composition and the use thereof. The five- and six-membered compound is a compound as shown in formula I, II or III. The compound has an inhibitory effect on FLT3 and/or IRAK4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.